Prescription drug · ANDA
Posaconazole NDC 17856-2133
Posaconazole 100 mg/1 · Tablet, Delayed release · Oral · ATLANTIC BIOLOGICALS CORP.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 17856-2133-1 | 1785621330117856213301 | 100 POUCH in 1 BOX, UNIT-DOSE (17856-2133-1) / 1 TABLET, DELAYED RELEASE in 1 POUCH (17856-2133-2)Marketed from May 9, 2024 | |
| 17856-2133-5 | 1785621330517856213305 | 59 POUCH in 1 BOX (17856-2133-5) / 1 TABLET, DELAYED RELEASE in 1 POUCHMarketed from Apr 20, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Posaconazole
- Generic name (nonproprietary)
- posaconazole
- Active ingredients
- Posaconazole — 100 mg/1
- Dosage form
- Tablet, Delayed release
- Route
- Oral
- Labeler
- ATLANTIC BIOLOGICALS CORP.NDC labeler code 17856
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 212411
- Marketing start
- Listing expires
- Other FDA classes
- Azoles (Chemical structure)
- Identifiers
- Product ID 17856-2133_4fea6190-d259-a7e3-e063-6394a90aa93fSPL ID 4fea6190-d259-a7e3-e063-6394a90aa93fSPL set ID dfbc636f-d8a7-4232-a6b0-cda49caadc9bRxCUI 1482908UNII 6TK1G07BHZ
- Pharmacologic class
- Azole Antifungal
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N417856213301followed by a unit qualifier and the quantityPackage 17856-2133-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Posaconazole delayed-release tablets is an azole antifungal agent indicated for: prophylaxis of invasive Aspergillus and Candida infections in patients who are at high risk of developing these infections due to being severely immunocompromised, such as HSCT recipients with GVHD or those with hematologic malignancies with prolonged neutropenia from chemotherapy. (1.1) 1.1 Prophylaxis of Invasive Aspergillus and Candida Infections Posaconazole delayed-release tablets are indicated for prophylaxis of invasive Aspergillus and Candida infections in patients who are at high risk of developing these infections due to being severely immunocompromised, such as hematopoietic stem cell transplant (HSCT…
Excerpt only. Read the full label for complete information.
About NDC 17856-2133
- What is NDC 17856-2133?
- 17856-2133 is the product NDC for Posaconazole, Posaconazole 100 mg/1 tablet, delayed release, listed with the FDA by ATLANTIC BIOLOGICALS CORP.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Posaconazole.
- What is the active ingredient?
- Posaconazole.
- Who is the labeler?
- ATLANTIC BIOLOGICALS CORP., NDC labeler code 17856. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Posaconazole?
- 32 other product NDCs are listed under this name. See all Posaconazole NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Posaconazole products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| posaconazole | Posaconazole 100 mg/1 | Tablet, CoatedOral | Novadoz Pharmaceuticals LLC | 72205-168 | 72205-0168-60 |
| Posaconazole | Posaconazole 18 mg/mL | SolutionIntravenous | Camber Pharmaceuticals, Inc. | 31722-370 | 31722-0370-31 |
| Posaconazole | Posaconazole 100 mg/1 | Tablet, Delayed releaseOral | Aurobindo Pharma Limited | 59651-596 | 59651-0596-60 |
| posaconazole | Posaconazole 18 mg/mL | Injection, SolutionIntravenous | GLENMARK PHARMACEUTICALS INC., USA | 68462-911 | 68462-0911-01 |
| Posaconazole | Posaconazole 100 mg/1 | Tablet, Delayed releaseOral | A2A Integrated Pharmaceuticals | 73141-023 | 73141-0023-02 |
| posaconazole | Posaconazole 18 mg/mL | SolutionIntravenous | Mylan Institutional LLC | 67457-665 | 67457-0665-20 |
| posaconazole | Posaconazole 18 mg/mL | Injection, SolutionIntravenous | GLENMARK PHARMACEUTICALS INC., USA | 68462-904 | 68462-0904-01 |
| Posaconazole | Posaconazole 18 mg/mL | InjectionIntravenous | Eugia US LLC | 55150-388 | 55150-0388-01 |
| Posaconazole | Posaconazole 18 mg/mL | Injection, SolutionIntravenous | Fresensius Kabi USA, LLC | 63323-685 | 63323-0685-17 |
| posaconazole | Posaconazole 18 mg/mL | Injection, SolutionIntravenous | Gland Pharma Limited | 68083-577 | 68083-0577-01 |
Other NDCs under ANDA 212411
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Posaconazole | Posaconazole 100 mg/1 | Tablet, Delayed releaseOral | Lannett Company Inc. | 0527-2133 |
| Posaconazole | Posaconazole 100 mg/1 | Tablet, Delayed releaseOral | American Health Packaging | 60687-523 |
| Posaconazoleposaconazole delayed-release | Posaconazole 100 mg/1 | TabletOral | Chartwell RX, LLC | 62135-429 |